Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg

ATTRwt-CA occurs in elderly patients and leads to severe heart failure. The disease mechanism involves cardiac and extracardiac infiltration by amyloid fibrils. The objectives of this study are to describe the frailty phenotype in patients with ATTRwt-CA and to assess the associations between frailt...

Full description

Bibliographic Details
Main Authors:	Amaury Broussier, Jean Philippe David, Mounira Kharoubi, Silvia Oghina, Lauriane Segaux, Emmanuel Teiger, Marie Laurent, Isabelle Fromentin, Sylvie Bastuji-Garin, Thibaud Damy
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Journal of Clinical Medicine
Subjects:	cardiac amyloidosis wild-type TTR amyloidosis (ATTRwt) frailty heart failure elderly geriatric assessment
Online Access:	https://www.mdpi.com/2077-0383/10/15/3415

Similar Items

The role of non-coding genetic variants on transthyretin gene transcription in transthyretin amyloidosis
by: Boldbaatar, Batbold
Published: (2021)

Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic
by: Krister Lindmark, et al.
Published: (2021-02-01)

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
by: Steven Law, et al.
Published: (2020-12-01)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
by: Bokyung Kim, et al.
Published: (2021-03-01)

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
by: Gabriela Molina O, et al.
Published: (2014-11-01)

Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis
by: Emily R. Soper, et al.
Published: (2021-01-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis
by: Florian Kocher, et al.
Published: (2020-12-01)

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
by: Ana Frangolho, et al.
Published: (2020-12-01)

Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis
by: Diana Michels da Silva, et al.
Published: (2019-05-01)

Glavonoid, a possible supplement for prevention of ATTR amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2021-10-01)

Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
by: Andreas Thimm, et al.
Published: (2019-09-01)

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
by: Massimo Russo, et al.
Published: (2020-12-01)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
by: Mounira Kharoubi, et al.
Published: (2021-04-01)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
by: Luca Gentile, et al.
Published: (2021-04-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Stroke risk and atrial mechanical dysfunction in cardiac amyloidosis
by: Brennan Ballantyne, et al.
Published: (2020-04-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)

Through thick and thin: Diagnosis of transthyretin cardiac amyloidosis through non-invasive multimodality imaging
by: Abidin, HAZ, et al.
Published: (2021)

Through thick and thin: Diagnosis of transthyretin cardiac amyloidosis through non-invasive multimodality imaging
by: Kasim, S., et al.
Published: (2021)

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis
by: Filipa Bezerra, et al.
Published: (2021-08-01)

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots
by: Michaela Auer-Grumbach, et al.
Published: (2020-07-01)

Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
by: Federica Saponaro, et al.
Published: (2020-11-01)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
by: Fourat Ridouani, et al.
Published: (2018-08-01)

A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
by: Ivan Urits, et al.
Published: (2020-08-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Transthyretin gene regulation in wild-type transthyretin amyloidosis
by: Hanson, Jacquelyn
Published: (2017)

Structural Stabilization of Human Transthyretin by <i>Centella asiatica</i> (L.) Urban Extract: Implications for TTR Amyloidosis
by: Fredrick Nwude Eze, et al.
Published: (2019-03-01)

AL Amyloidosis
by: Desport Estelle, et al.
Published: (2012-08-01)

Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
by: Rizk M, et al.
Published: (2017-11-01)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
by: Ana Devesa, et al.
Published: (2021-08-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
by: Faruk Uğur Doğan, et al.
Published: (2019-03-01)

Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
by: Benjamin Terrier, et al.
Published: (2017-08-01)

AMYLOIDOSIS HEART IN ELDERLY
by: L. I. Dvoretsky, et al.
Published: (2015-12-01)

Disease-Modifying Therapy for Transthyretin Amyloidosis
by: Nowell M. Fine, MD, SM
Published: (2020-11-01)

Increased Risk of Multiple Outpatient Surgeries in African-American Carriers of <i>Transthyretin</i> Val122Ile Mutation Is Modulated by Non-Coding Variants
by: Renato Polimanti, et al.
Published: (2019-02-01)

Revisiting transthyretin related cardiac amyloidosis: Case report and review of literature
by: Munish Sharma, et al.
Published: (2018-05-01)